What the GLOW peptide blend contains (GHK-Cu, BPC-157 and TB-500), how its certificate is read, and what the published research covers.
Written by the Peptide Labs Research Team
GLOW is a three-component research peptide blend: GHK-Cu, BPC-157 and TB-500 in one lyophilised vial. Peptide Labs' 70mg GLOW vial contains 50mg GHK-Cu, 10mg BPC-157 and 10mg TB-500, with each component quantified on its certificate of analysis. It is sold for in-vitro laboratory research only.
| Component | What it is | Amount per 70mg vial |
|---|---|---|
| GHK-Cu | Copper complex of the tripeptide glycyl-L-histidyl-L-lysine | 50mg |
| BPC-157 | Synthetic 15-amino-acid peptide derived from a gastric protein sequence | 10mg |
| TB-500 | Synthetic fragment (Ac-LKKTETQ) of thymosin beta-4 | 10mg |
"GLOW" is a catalogue name. It does not identify a single molecule, so any published research has to be read component by component.
Three. A blend does not have a single purity figure the way a single compound does. The catalogue lists a combined HPLC purity of 99.0%, and the certificate of analysis is the document to read for the detail on each component. Check that every component is reported and that the batch number on the vial matches the report. The guide to reading a peptide COA explains each section.
Most of the published work on all three is preclinical, meaning cell culture and rodent studies. It does not establish effects in people, and a finding on one component does not carry over to the same component inside a mixture.
We are not aware of a published study that evaluates this exact three-component combination.
The "Wolverine stack" is the nickname for BPC-157 plus TB-500 only. GLOW adds GHK-Cu as a third component. The Wolverine stack explainer covers the two-component pairing.
No. GLOW is a lyophilised powder supplied in a vial for laboratory research. Skincare serums that contain copper peptides are cosmetics formulated for a different purpose. Skincare peptides versus research peptides explains the difference.
Published reports are in the COA library, and the GLOW product page lists the current batch.
Peptide Labs supplies GLOW strictly for in-vitro laboratory research. It is not approved by the TGA for any therapeutic use, it is not for human or animal use, and this article gives no dosing, preparation or use guidance.
Aussie Peptides closed on 20 October 2026 after a 40% off closing sale. The owner says the TGA shut it down. Here is what is known.
Quality & TestingWhat HPLC and mass spectrometry test in a research peptide, what a COA shows, and how to check a certificate is genuine.
99%+ HPLC purity · COA verified every batch · Next-day dispatch to Melbourne
Shop All Peptides